Literature DB >> 23216550

Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.

Takehide Fujimoto1, Hirotsugu Imaeda, Kenichiro Takahashi, Eiji Kasumi, Shigeki Bamba, Yoshihide Fujiyama, Akira Andoh.   

Abstract

BACKGROUND AND AIMS: Dysbiosis is thought to be relevant to the etiology and pathogenesis of Crohn's disease (CD). In this study, we investigated the abundance of Faecalibacterium prausnitzii, as well as Bilophila wadsworthia, in the gut microbiota of Japanese CD patients.
METHODS: Forty-seven CD patients and 20 healthy controls were enrolled. Abundance of F. prausnitzii in fecal samples was quantified by real-time polymerase chain reaction. The gut microbiota profile was evaluated by terminal restriction fragment length polymorphisms.
RESULTS: The abundance of F. prausnitzii significantly decreased in CD patients compared with healthy subjects. B. wadsworthia was scarcely detected in the same samples. Among CD patients, the Crohn's Disease Activity Index, C-reactive protein levels, and erythrocyte sedimentation rate were significantly lower, and serum albumin levels were significantly higher in the high F. prausnitzii group compared with the low group. Terminal restriction fragment length polymorphisms analysis showed that fecal bacterial communities of CD patients differed from those of healthy individuals. The changes in simulated bacterial composition indicated that class Clostridia, including genus Faecalibacterium, was significantly less abundant in CD patients as compared with healthy individuals. The bacterial diversity measured by the Shannon Diversity Index was significantly reduced in CD patients compared with healthy individuals.
CONCLUSION: The decreased abundance of class Clostridia, including F. prausnitzii, may translate into a reduction of commensal bacteria-mediated, anti-inflammatory activities in the mucosa, which are relevant to the pathophysiology of CD. In contrast, the role of B. wadsworthia was suspected to be minimal.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23216550     DOI: 10.1111/jgh.12073

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  92 in total

1.  Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria.

Authors:  Jessica L Sessenwein; Corey C Baker; Sabindra Pradhananga; Megan E Maitland; Elaine O Petrof; Emma Allen-Vercoe; Curtis Noordhof; David E Reed; Stephen J Vanner; Alan E Lomax
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

Review 2.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

3.  Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.

Authors:  David L Suskind; Mitchell J Brittnacher; Ghassan Wahbeh; Michele L Shaffer; Hillary S Hayden; Xuan Qin; Namita Singh; Christopher J Damman; Kyle R Hager; Heather Nielson; Samuel I Miller
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

Review 4.  A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.

Authors:  Takanori Kanai; Yohei Mikami; Atsushi Hayashi
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

5.  Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.

Authors:  Femke-Anouska Heinsen; Henrik Knecht; Sven C Neulinger; Ruth A Schmitz; Carolin Knecht; Tanja Kühbacher; Philip C Rosenstiel; Stefan Schreiber; Anette K Friedrichs; Stephan J Ott
Journal:  Gut Microbes       Date:  2015-07-04

6.  Diet Versus Phylogeny: a Comparison of Gut Microbiota in Captive Colobine Monkey Species.

Authors:  Vanessa L Hale; Chia L Tan; Kefeng Niu; Yeqin Yang; Rob Knight; Qikun Zhang; Duoying Cui; Katherine R Amato
Journal:  Microb Ecol       Date:  2017-07-22       Impact factor: 4.552

Review 7.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

8.  Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.

Authors:  Holger Schäffler; Annika Kaschitzki; Christian Alberts; Peggy Bodammer; Karen Bannert; Thomas Köller; Philipp Warnke; Bernd Kreikemeyer; Georg Lamprecht
Journal:  Int J Colorectal Dis       Date:  2016-03-07       Impact factor: 2.571

Review 9.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

10.  Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

Authors:  Yun-Xia Chen; Li-Na Lai; Hui-Ying Zhang; Yang-Hui Bi; Li Meng; Xu-Jiong Li; Xiao-Xia Tian; Li-Min Wang; Yi-Min Fan; Zhong-Fu Zhao; De-Wu Han; Cheng Ji
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.